In a patient cohort with end-stage liver disease and mixed disease etiology, a negative correlation of serum PCSK9 concentrations with the MELD score was observed and low PCSK9 levels were associated with a higher mortality [24]. Here, PCSK9 is linked to End Stage Liver Disease.